Evidence map›Paper›PMID 32592501›Full record

ReviewJournal of medical virology2021

The cytokine storm and COVID-19.

Biying Hu, Shaoying Huang, Lianghong Yin

3 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in Journal of medical virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 927 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
927citing papers in PubMed, 7 pooled it
30.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04531345 completednot on this map

The Cytokine Status of Covid-19 Patients

TypeobservationalSponsorIstanbul Training and Research HospitalRan2020 to 2020Enrolled60ConditionsCovid19ArmsFlow cytometric analysis
NCT05124158 completednot on this map

Association of the Severity of the Clinical Picture of COVID-19 and Psychiatric Morbidity

Typeobservational_patient_registrySponsorInstituto Mexicano del Seguro SocialRan2021 to 2022Enrolled78ConditionsCOVID-19, Psychiatric Disorder
NCT05304702 completednot on this map

Lung Injury (Pulmonary Edema) in COVID-19: Treatment With Furosemide and Negative Fluid Balance (NEGBAL): a Case-Control Study

TypeobservationalSponsorClinica ColonRan2021 to 2022Enrolled120ConditionsCOVID-19
3 · Its place in the literature

Who cites it

927 citing papers in PubMed, 7 syntheses or guidelines pooled it, 1,668 citations in OpenAlex.

  1. Pooled it
  2. Impact of air pollution on COVID-19 severity: a systematic review of underlying biological mechanisms.European respiratory review : an official journal of the European Respiratory Society · 2025
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Impacts of COVID-19 on pediatric patients with congenital heart disease: a small systematic and integrative literature review.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2025
    Pooled it
  8. Trial
  9. Gut microbial allies and adversaries in SARS-CoV-2 infection.Current research in microbial sciences · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Observational

867 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Biying HuThe First Clinical Medical College of Jinan University, The First Affiliated Hospital of Jinan University, Guangzhou, China.ORCID 0000-0002-4871-2539
Shaoying HuangShenzhen People's Hospital, The Second Clinical Medical College of Jinan University, Shenzhen, China.ORCID 0000-0002-4607-6743
Lianghong YinThe First Clinical Medical College of Jinan University, The First Affiliated Hospital of Jinan University, Guangzhou, China.
First Affiliated Hospital of Jinan University · CNJinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), which began in Wuhan, China, in December 2019, has caused a large global pandemic and poses a serious threat to public health. More than 4 million cases of COVID-19, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have been confirmed as of 11 May 2020. SARS-CoV-2 is a highly pathogenic and transmissible coronavirus that primarily spreads through respiratory droplets and close contact. A growing body of clinical data suggests that a cytokine storm is associated with COVID-19 severity and is also a crucial cause of death from COVID-19. In the absence of antivirals and vaccines for COVID-19, there is an urgent need to understand the cytokine storm in COVID-19. Here, we have reviewed the current understanding of the features of SARS-CoV-2 and the pathological features, pathophysiological mechanisms, and treatments of the cytokine storm induced by COVID-19. In addition, we suggest that the identification and treatment of the cytokine storm are important components for rescuing patients with severe COVID-19.

Indexed as

Clinical Trials as TopicCOVID-19COVID-19 Drug TreatmentCytokine Release SyndromeHumansLungSeverity of Illness IndexCOVID-19cytokine stormliterature reviewSARS-CoV-2

Identifiers

PMID32592501
PMCPMC7361342
OpenAlexW3037185429

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.